Cyclerion Therapeutics Inc. (CYCN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cyclerion Therapeutics In...

    NASDAQ: CYCN · Real-Time Price · USD
    2.44
    -0.29 (-10.62%)
    At close: Sep 26, 2025, 1:16 PM

    Cyclerion Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 2M n/a 297K 3.32M
    Cost of Revenue
    		 n/a n/a 65K 472K
    Gross Profit
    		 2M n/a 232K 2.85M
    Operating Income
    		 -3.63M -9.65M -44.37M -55.2M
    Interest Income
    		 208K 358K 294K n/a
    Pretax Income
    		 -3.06M -12.59M -44.08M -51.65M
    Net Income
    		 -3.06M -21.02M -43.78M -51.66M
    Selling & General & Admin
    		 5.34M 8.13M 14.5M 20.62M
    Research & Development
    		 286K 1.51M 31.49M 37.64M
    Other Expenses
    		 n/a n/a -1.33M -622K
    Operating Expenses
    		 5.63M 9.65M 44.67M 57.63M
    Interest Expense
    		 n/a n/a 294K 16K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 5.63M 9.65M 44.67M 57.63M
    Income Tax Expense
    		 n/a n/a -294K 16K
    Shares Outstanding (Basic)
    		 2.52M 2.34M 2.17M 1.96M
    Shares Outstanding (Diluted)
    		 2.52M 2.34M 2.17M 1.96M
    EPS (Basic)
    		 -1.21 -8.99 -20.15 -26.4
    EPS (Diluted)
    		 -1.21 -8.99 -20.15 -26.4
    EBITDA
    		 -3.63M -12.59M -18.18M -55.2M
    EBIT
    		 -3.63M -12.59M -18.54M -54.31M
    Depreciation & Amortization
    		 n/a -2.95M 65K 472K

    Add to Watchlist